© Copyright 2025 American Medical Association. All rights reserved.
The procedure described by CPT® Code 0071T involves the focused ultrasound ablation of uterine leiomyomata, commonly known as uterine fibroids, utilizing magnetic resonance (MR) guidance. This innovative technique, referred to as magnetic resonance-guided focused ultrasound surgery (MRgFUS), is a noninvasive method aimed at treating symptomatic uterine fibroids while minimizing associated risks. The procedure leverages high-intensity focused ultrasound (HIFU) to precisely target and destroy fibroid tissue. The integration of MR imaging allows for real-time guidance and monitoring, ensuring that the treatment is accurately directed at the fibroids. Prior to the ablation, a three-plane localizer MR scan is conducted to confirm the correct positioning of the patient on the treatment table, which is crucial for the success of the procedure. The targeted fibroid is identified, and advanced treatment software is employed to establish the optimal treatment routes and settings for the ablation dose. This process includes the creation of three-dimensional (3D) renderings and simulations that are reviewed to finalize the treatment plan. The procedure is performed under conscious sedation, allowing the patient to remain awake and communicate any sensations to the medical team. Safety measures are in place, including an emergency shut-off button accessible to the patient, assistant, and physician. During the sonication phase, continuous MR imaging is utilized to ensure the precise destruction of the leiomyoma by focusing a high-energy ultrasound beam on the fibroid, raising its temperature to between 60 and 80 degrees Celsius. If multiple fibroids are present, the procedure is repeated for each one, following the same targeting, imaging, analysis, and destruction protocols. This code is specifically applicable when the total volume of the leiomyomata is less than 200 cc of tissue.
© Copyright 2025 Coding Ahead. All rights reserved.
The focused ultrasound ablation of uterine leiomyomata, as described by CPT® Code 0071T, is indicated for patients experiencing symptoms related to uterine fibroids. These symptoms may include:
The procedure for focused ultrasound ablation of uterine leiomyomata involves several critical steps to ensure effective treatment:
After the focused ultrasound ablation procedure, patients may experience some discomfort or mild pain, which can typically be managed with over-the-counter pain relief. Monitoring for any immediate complications is essential, and patients are usually advised to rest and avoid strenuous activities for a short period. Follow-up appointments may be scheduled to assess the effectiveness of the treatment and to monitor for any recurrence of symptoms. It is important for patients to report any unusual symptoms or concerns to their healthcare provider during the recovery phase.
Short Descr | US LEIOMYOMATA ABLATE <200 | Medium Descr | US ABLATJ UTERINE LEIOMYOMATA < 200 CC TISSUE | Long Descr | Focused ultrasound ablation of uterine leiomyomata, including MR guidance; total leiomyomata volume less than 200 cc of tissue | Status Code | Carriers Price the Code | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 0 - Physician Service Code | Multiple Procedures (51) | 0 - No payment adjustment rules for multiple procedures apply. | Bilateral Surgery (50) | 0 - 150% payment adjustment for bilateral procedures does NOT apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 0 - Payment restriction for assistants at surgery applies to this procedure... | Co-Surgeons (62) | 0 - Co-surgeons not permitted for this procedure. | Team Surgery (66) | 0 - Team surgeons not permitted for this procedure. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Hospital Part B services paid through a comprehensive APC | Type of Service (TOS) | 2 - Surgery | Berenson-Eggers TOS (BETOS) | I4B - Imaging/procedure - other | MUE | 1 | CCS Clinical Classification | 131 - Other non-OR therapeutic procedures, female organs |
Date
|
Action
|
Notes
|
---|---|---|
2005-01-01 | Added | First appearance in code book in 2005. |
Get instant expert-level medical coding assistance.